While Celestica shows strong fundamental growth metrics (90.51% EPS growth, 69.1% revenue growth) and recent stock outperformance (+19.08% over past month), the neutral sentiment is justified by: (1) a Hold rating (Zacks Rank #3), (2) trading at a significant valuation premium (Forward P/E of 31.48 vs. industry average of 24.79), and (3) stagnant analyst estimate revisions over the past 30 days, suggesting limited near-term upside catalysts despite solid earnings expectations.
Celestica news
About Celestica
Despite overwhelmingly positive brokerage recommendations (18 Strong Buy, 1 Buy), the Zacks Rank #3 (Hold) rating and unchanged consensus earnings estimate of $11.32 suggest the stock is expected to perform in line with the market. The article advises caution against the bullish ABR, indicating neutral near-term prospects.
Strong earnings growth expectations (90.51% EPS growth, 69.1% revenue growth YoY), Zacks Rank #1 (Strong Buy) rating, outperformance versus S&P 500, and 16.04% monthly gain indicate positive momentum and analyst optimism for the company's near-term prospects.
Strong Buy rating from Zacks, significant earnings estimate increases (11.4% for 2026, 30.2% for 2027), well-positioned in growing HealthTech market with comprehensive portfolio and global manufacturing capabilities. However, shares underperformed industry by 11% over past year.
Strong projected growth (64.27% sales, 87.11% EPS for 2026), robust demand for networking products, strategic partnerships with OpenAI/AMD/Broadcom, improved cash flow generation, attractive valuation (P/E 20.04), and Zacks Rank #1 (Strong Buy) rating.
Celestica received a Zacks Rank #1 (Strong Buy) rating supported by a 3.3% increase in consensus earnings estimates over the past month. While 18 of 19 brokerage firms issued Strong Buy ratings, the article emphasizes that the Zacks Rank—based on earnings estimate revisions rather than analyst sentiment—is a more reliable predictor of near-term stock performance, providing legitimate fundamental support for the bullish outlook.
Stock fell 15.37% despite beating earnings expectations and raising full-year guidance significantly. The disconnect between strong financial results and sharp stock decline indicates investor concerns about valuation or market conditions outweighing positive fundamentals.
Despite beating earnings estimates on both EPS and revenue, and raising full-year guidance, the stock declined 7.11% in after-hours trading. This disconnect between strong financial results and negative price action suggests investor concerns about valuation, forward guidance expectations, or market conditions that outweigh the positive earnings report.
Strategic partnership with AMD to manufacture AI infrastructure components demonstrates market opportunity in growing AI sector. Stock price up 4.71% on announcement, analyst consensus is Buy with $288.44 price target, and company shows strong growth trajectory (201.42% over 12 months). Partnership leverages company's engineering and manufacturing capabilities in high-demand AI market.
Also mentions CLS
Articles that tag CLS but are mainly about other companies.
Mentioned as a peer competitor in AI infrastructure manufacturing with comparable 1-year performance (+48.5%), but no specific company-focused analysis provided.
Operating cash flow increased 171% to $767.2 million in H1 2026, driven by higher cash earnings and favorable working capital changes. However, high capital expenditures are limiting free cash flow growth, creating a mixed outlook.
Competitive peer with presence in 16 countries and 40+ sites. Actively expanding capacity in U.S., Thailand, and Malaysia for AI/ML and HPC programs. Positioned similarly to Jabil in mitigating geopolitical volatility, but no specific financial performance metrics provided.
Underperformed both Jabil and Flex with only 5.7% year-to-date gain, suggesting weaker competitive positioning despite operating in the same industry.
Strong Q2 performance with 62.4% revenue growth to $4.70B and 82.7% adjusted EPS growth to $2.54. Raised 2026 outlook to $20.5B revenues and $11.30 adjusted EPS. Holds Zacks Rank #1 (Strong Buy) with rising earnings estimates.
Listed as a leading market player but no specific recent developments or expansion activities mentioned in the article.
Electronics manufacturing services company assembles advanced chips into custom liquid-cooled AI server racks and builds networking switches. Positioned as critical infrastructure architect in AI supply chain. Benefits from hyperscalers' shift toward proprietary custom hardware and locked into multi-year data center buildout contracts.
Integrates GPUs and networking gear into AI racks for hyperscalers; positioned as primary assembler for Anthropic's infrastructure expansion with recent product launches.
Handles system-level board and rack assembly for Google's AI server deployments. Benefits directly from Google's escalating capex commitment and TPU supply chain expansion.
Mentioned as a top holding of Divisadero Street Capital Management ($86.14 million, 4.0% of AUM) but no specific news or analysis provided about the company itself.
Largest holding in CGI's portfolio at 6.0%, indicating confidence in the company's prospects
Rose 0.68% with strong price trend and good quality score. Upcoming earnings report of $2.07 per share expected after market close.
Included as underlying holding in Ninepoint Celestica HighShares ETF with $0.21 monthly distribution. No company-specific developments mentioned; neutral reference as ETF component.
Partnership with AMD to design and manufacture scale-up switches for large-scale clustering of AMD products. This partnership is identified as a key catalyst that helps clear the path for MI450 deployments at scale, which is critical to unlocking AMD's revenue and earnings outlook.
Included in the new HighShares ETF lineup, reflecting Ninepoint's selection of the company as worthy of single-stock ETF investment exposure.
Strong beneficiary of AI data center spending with 50% expected growth in connectivity and cloud solutions business in 2026. Trading at discount valuation (3x sales vs. 5.4x for Nasdaq), with potential market cap to double if it trades at index average multiples.
Articles and sentiment ratings from Massive / Polygon. Sentiment is the provider's model rating for this company, not Gainbot's view.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology